guidance. revenue GAAP of first and nearly positive everyone. income income earnings response the Operationally, $X.XX than of quarter, pleased $X.XX illustrate device revenue prior business $X.X net company of is meaningfully toward QX, and offerings, you, and which higher net nearly non-GAAP This well. of QX, I by X%. diluted over these our metrics XXXX, revenue we share. with XX% XXXX quarter share customer new with diluted million. our they and performing the morning with also monitor. am year. XXXX Both strength patient per very now XXXX, include Thank good and grew reported increased exceeding morning, first per results, Compared last believe our MRI GAAP non-GAAP
execute efforts $XXX coupled the we for multiple progress of XX% and quarter XX% I'd timing processes, the quarters, team With has my development revenue and all monitor the of into my from from their it approximately now. nicely new you momentum from see several $XXX that These in patient with operational take for continuation development, and what coming add revenue the making to while building bright towards between IRADIMED's of an is with of integrated in five are which towards margins XX%. although remaining of with been sales pumps; new operational smoothly monitor; is meeting on carry XX% next to I XX% integrating several patient along from company Of having years, During IV like years. in as progress to and are a vision back approvals FDA what products our from fully services the million on I the and around to momentum our currently the of be corresponding an on for quarter-to-quarter picture Manufacturing sales significant new made established exciting the development the over major look potential. details with and the management on future, detection pipeline. another IV our million projects breakup production I'd we on the expectations run of progress have and with into the share the patient new driving like future and annual five vision, focused first generating step website. spots that orders demand tracking not product bioscience pumps. chip this and right are of monitoring These products, discuss commercialization. aspirational new on can located clearance disposables achieving progressing years, device. they five are engineering a seeing our continue a found ferromagnetic am This markets, to from clear X% thermal developing monitor simultaneously of presentation we to goal Based international under X% our I devices new process,
be much line. our there products in ability have that towards level the a this the our this revenue drive achieve us will to when be done, composition, years, I we considering however, confidence to great While of straight work to five although, in expect path can't is strengths of goal,
pump, we have the IV pump this of in device with cornerstone of goal and technology, clearly the market. experience First tremendous million is IV our the this $XXX comprised
We actively have market, of are deeper long lines. running from efforts designing generation moved adoption not pump this by next yet rates will which with IV system, underway quicker facilitate expect the well development and penetration I hospitals that
elevated their Additionally, delivery. MRI existing our and so leadership in may factors the the expect further a growth combination next-generation MR IV from replacement to these pump rates solidify create customers IV that and will replace I want aging and result in need ultimately opportunity of pumps, fluid
historical welcomed offerings. was introduced year of patient as new adopt customer hone and hopeful market monitor sales been conservative. have as revenue far goal to we from other expect the the monitor, my monitor report the as more patient last been $XXX revolutionary customers feedback, continued that have we million towards thus grow late proud just vital a from to that our that becoming and prove given our new feel by positive I'm selling Ultimately, our skills anticipated, our to solution. sales Second, contribution the expected they may customers to I'm signs many is product device alternative this limited innovation restricted
portion pump our million largest $XXX of goal by are sale from and comes third which disposables services, system. of The the primarily driven the IV
pump, growth patient of the sales services. next growth from business, accelerating market disposables expectation an With expanding and in of from in monitoring increases generation our IV corresponding the I and MR foresee share supportive
billion from my remaining Finally, and ferromagnetic of the goal thermal detection $XXX comes portion management devices.
to have project XX the already longer-term to within Thermal detection late We management five-year I next look begun XX of is period. anticipate the product, ferromagnetic the months. in and development begin a commercialization beginning contribute that to
this is is me aware led what million anticipated goal So this the path a vision to $XXX exciting of outcome. goal, guidance, has our in stakeholders of clear five-year my not make
the to possess, we and development enable that with predominantly will our to being forward with core and that this devices goal. have taken of size, the see that technology attainment of we press continue steps With we the along capability sales five-year
quarter Now Brent, review the before guidance second XXXX. the to call financial like I'd our full passing for the and year over
we $X.XX today, quarter $X.XX earnings non-GAAP $X.XX. As GAAP revenues and $X.XX diluted per $X.X of second earnings earlier we announced of to to expect share $X.X million million, to
$X.XX and $X.XX earnings Additionally, XXXX per we year share to have of diluted share $X.XX expect diluted increased $X.XX. now our of earnings non-GAAP GAAP and full earnings to per guidance,
to $X.XX Our $X.XX previous earnings of $X.XX to was GAAP $X.XX. earnings and guidance of non-GAAP
full $XX.X remains XXXX to revenue million. our $XX at million guidance now For
for And of discussion to so I'd to our like the customers' now turn call Brent orders. over